Stock Events

Stock Events

Hyperion DeFi 

€2.66
92
-€0.16-5.67% Thursday 07:55

Statistics

Day High
2.66
Day Low
2.66
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
21.54M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q1 2025
Q2 2025
Q3 2025
Next
-6.19
-3.75
-1.3
1.14
Expected EPS
1.1436348
Actual EPS
N/A

Financials

-86,995.02%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
109,116.45Revenue
-94.93MNet Income

Analyst Ratings

$4.65Average Price Target
The highest estimate is 6.26.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow B0U.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Novartis, through its Alcon division, provides a broad portfolio of eye care products, directly competing with Eyenovia's therapeutic solutions.
Bausch Health Companies
BHC
Mkt Cap2.62B
Bausch Health Companies, through its Bausch + Lomb segment, offers products that compete in the same eye health categories as Eyenovia.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its Vision Care division, competes in the eye health market, offering products that could rival Eyenovia's treatments.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals provides treatments for eye diseases, including Eylea, directly competing with Eyenovia's eye therapy solutions.
Alcon
ALC
Mkt Cap36.88B
Alcon focuses on eye care products across a wide range of areas, directly competing with Eyenovia's innovative eye therapies.
Pfizer
PFE
Mkt Cap140.15B
Pfizer offers various pharmaceutical products, including treatments for eye conditions, competing with Eyenovia's therapeutic approach.
Rogers
ROG
Mkt Cap1.57B
Roche, through its ophthalmology division, develops treatments for eye diseases, competing with Eyenovia's focus on eye care solutions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries offers generic and specialty medicines, including ophthalmic products, competing with Eyenovia's niche in eye care.

About

A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.
Show more...
CEO
ISIN
US30234E2037
WKN
000A40ZAN

Listings

XNAS
US
HYPD
F
DE
B0U.F
BOATS
BOATS
HYPD.BOATS

0 Comments

Share your thoughts

FAQ

What is Hyperion DeFi stock price today?▼
The current price of B0U.F is €2.66 EUR — it has decreased by -5.67% in the past 24 hours. Watch Hyperion DeFi stock price performance more closely on the chart.
What is Hyperion DeFi stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Hyperion DeFi stocks are traded under the ticker B0U.F.
What is Hyperion DeFi market cap?▼
Today Hyperion DeFi has the market capitalization of 21.54M
When is the next Hyperion DeFi earnings date?▼
Hyperion DeFi is going to release the next earnings report on May 07, 2026.
What were Hyperion DeFi earnings last quarter?▼
B0U.F earnings for the last quarter are 0.04 EUR per share, whereas the estimation was -6.19 EUR resulting in a +100.69% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Hyperion DeFi revenue for the last year?▼
Hyperion DeFi revenue for the last year amounts to 109,116.45 EUR.
What is Hyperion DeFi net income for the last year?▼
B0U.F net income for the last year is -94.93M EUR.
When did Hyperion DeFi complete a stock split?▼
Hyperion DeFi has not had any recent stock splits.